Split thread Er,... Valcyte, Valtrex, Ampligen, oxymatrine, tenofovir, low-dose naltrexone, GcMAF, Pridgen protocol (for fibromyalgia).
And if you had made this list half a year ago Rituximab would have been on the list. There is absolutely not enough evidence at this moment to conclude that any of these provide an effective treatment of ME/CFS.
True, but that does not imply patients are not benefiting from these treatments. Formal evidence is not there because even when promising ME/CFS treatments are developed, nobody bothers to take it further and perform a large-scale clinical trial. For example, Martin Lerner's blinded randomized placebo-controlled trial treating 27 Epstein-Barr ME/CFS patients with Valtrex culminated in improvements over placebo at 6 months. That study was published in 2007, but nobody has performed a replication study in the intervening decade. Rituximab is still being used as an ME/CFS treatment in Norway by the way; although we know the response rate is low and the risks of serious adverse effects seem significant.
I don't know. We know in Whitney Dafoe and Olaf Bodden there was a significant worsening of ME/CFS, so that's one adverse outcome that can occur.
I don't know the exact circumstances, and I think timing of events is important in allocating cause: if these patients were stable for many years in their ME/CFS, and then right after the infusions became severely worse, that would suggest a causal relationship.
We struck a technical glitch that prevented people posting to this thread when it was located in the 'Treatments' subforum. The thread has been moved to the Treatments>Rituximab sub-subforum while we get an appropriate sub-subforum heading arranged. Sorry for the inconvenience and confusion.